GlassScriptPhysician profile
Sheila Asghar
NPI 1508064445
$2,593.46
in general payments reported to CMS, 2019-2025
33 companies · $1,028 in 2025
The $1,028 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
See the full distribution for Neurology with Special Qualifications in Child Neurology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $58.01 · 2021: $119 · 2022: $314 · 2023: $396 · 2024: $679 · 2025: $1,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,102.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $230.63 | 2022-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Emd Serono, INC. | $223.56 | 2022-2025 | Mavenclad |
| Acadia Pharmaceuticals INC | $212.03 | 2023-2025 | Nuplazid, Daybue |
| Neurocrine Biosciences, INC. | $175.61 | 2023-2025 | Ingrezza |
| Ucb, INC. | $168.89 | 2022-2025 | Briviact, Nayzilam, Fintepla |
| Alexion Pharmaceuticals, INC. | $156.77 | 2021-2024 | Ultomiris, Soliris |
| Genentech USA, INC. | $135.94 | 2021-2025 | Ocrevus Zunovo, Ocrevus |
| Neurelis, INC. | $134.98 | 2021-2024 | Valtoco |
| Biomarin Pharmaceutical INC. | $120.73 | 2025 | |
| Genzyme Corporation | $103.87 | 2023-2025 | |
| Biogen, INC. | $98.35 | 2023-2025 | Vumerity, Spinraza, Qalsody |
| Inspire Medical Systems, INC. | $96.69 | 2025 | Inspire |
| Mallinckrodt Hospital Products INC. | $87.61 | 2021-2024 | Acthar |
| Biohaven Pharmaceutical Holding Company LTD. | $75.86 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $63.58 | 2023-2024 | Austedo Xr, Ajovy |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $61.11 | 2020-2025 | |
| Sk Life Science, INC. | $59.25 | 2022-2024 | |
| Argenx US, INC. | $53.17 | 2022-2023 | Vyvgart |
| Ani Pharmaceuticals, INC. | $51.87 | 2024 | Purified Cortrophin Gel |
| Eisai INC. | $33.96 | 2025 | |
| Upsher-Smith Laboratories LLC | $27.74 | 2024 | |
| Amneal Pharmaceuticals LLC | $27.65 | 2023 | Rytary |
| Biohaven Pharmaceuticals, INC. | $24.03 | 2021 | |
| Merz Pharmaceuticals, LLC | $22.37 | 2024 | Xeomin |
| Greenwich Biosciences, INC. | $18.49 | 2020 | |
| Immedica Pharma US, INC. | $18.06 | 2023 | |
| Tanabe Pharma America, INC. | $17.19 | 2024 | |
| Novo Nordisk INC | $17.17 | 2020 | |
| Impel Pharmaceuticals INC. | $16.73 | 2022 | |
| Amgen INC. | $16.70 | 2022 | |
| Xeris Pharmaceuticals, INC. | $16.26 | 2024 | Keveyis |
| Lundbeck LLC | $14.15 | 2024 | Vyepti |
| Mdd US Operations, LLC | $12.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Asghar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.